BUPIVACAINE HYDROCHLORIDE injection, solution
BUPIVACAINE HYDROCHLORIDE injection, solution is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: BUPIVACAINE HYDROCHLORIDE injection, solution; Generic name: BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION; Manufacturer: HF Acquisition Co LLC, DBA HealthFirst.
| Brand name | BUPIVACAINE HYDROCHLORIDE injection, solution |
|---|---|
| Generic name | BUPIVACAINE HYDROCHLORIDE INJECTION, SOLUTION |
| Manufacturer | HF Acquisition Co LLC, DBA HealthFirst |
| Used for | 1 INDICATIONS AND USAGE Bupivacaine hydrochloride injection is indicated in adults for the production of local or regional anesthesia or analgesia for surgery, oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. Specific concentrations and presentations of bupivacaine hydrochloride injection are recommended for each type of block indicated to produce local or regional anesthesia or analgesia [see DOSAGE AND ADMINISTRATION ]. Limitations of Use Not all blocks are indicated for use with bupivacaine hydrochloride injection given clinically significant risks associated with use [see DOSAGE AND ADMINISTRATION , CONTRAINDICATIONS , WARNINGS AND PRECAUTIO |
| Dosage | 2 DOSAGE AND ADMINISTRATION 2.1 Important Dosage and Administration Information Bupivacaine hydrochloride injection is not for intrathecal use. Avoid use of bupivacaine hydrochloride injection solutions containing antimicrobial preservatives (i.e., multiple-dose vials) for epidural or caudal anesthesia [see WARNINGS AND PRECAUTIONS ]. Discard unused portions of solution not containing preservatives, i.e., those supplied in single-dose vials, following initial use. Visually inspect this product f |
| Warnings | BOXED WARNING WARNING: RISK OF CARDIAC ARREST WITH USE OF BUPIVACAINE HYDROCHLORIDE IN OBSTETRICAL ANESTHESIA There have been reports of cardiac arrest with difficult resuscitation or death during use of bupivacaine hydrochloride for epidural anesthesia in obstetrical patients. In most cases, this has followed use of the 0.75% (7.5 mg/mL) concentration. Resuscitation has been difficult or impossible despite apparently adequate preparation and appropriate management. Cardiac arrest has occurred a |
| Active ingredient(s) | BUPIVACAINE HYDROCHLORIDE |
| Route | PERINEURAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=06c15208-c600-7173-e063-6394a90a2f94 |